Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (SHA:603168)
China · Delayed Price · Currency is CNY 7.42
+0.10 (1.37%)
Feb 4, 2026, 3:00 PM CST
SHA:603168 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -65.05 | -123.44 | 25.41 | 44.75 | 35.66 | -179.37 |
Depreciation & Amortization | 72.61 | 72.61 | 73.02 | 65.83 | 61.67 | 65.04 |
Other Amortization | 1.34 | 1.34 | 1.93 | 2.27 | 1.5 | 0.25 |
Loss (Gain) From Sale of Assets | -1.05 | -1.05 | 0.01 | -15.82 | 0.21 | 1.41 |
Asset Writedown & Restructuring Costs | 33.34 | 33.34 | 13.3 | 9.48 | - | 105.92 |
Loss (Gain) From Sale of Investments | 16.67 | 16.67 | -16.02 | 2.51 | -7.21 | -7.74 |
Provision & Write-off of Bad Debts | 1.17 | 1.17 | -3.09 | 4.32 | 1.72 | -0.22 |
Other Operating Activities | 2.43 | 12.4 | 5.52 | -5.96 | 2.75 | 15.17 |
Change in Accounts Receivable | -2.33 | -2.33 | -12.04 | 6.83 | -4.19 | 22.29 |
Change in Inventory | 5.05 | 5.05 | -25.32 | -0.15 | 4.11 | 18.01 |
Change in Accounts Payable | 9.09 | 9.09 | -7.72 | 1 | 4.55 | 28.47 |
Change in Other Net Operating Assets | 0.87 | 0.87 | -12.28 | - | - | -25.85 |
Operating Cash Flow | 74.09 | 25.67 | 41.49 | 115.72 | 100.78 | 44.09 |
Operating Cash Flow Growth | 27.01% | -38.13% | -64.14% | 14.82% | 128.58% | -25.86% |
Capital Expenditures | -92.29 | -128.11 | -219.8 | -148.69 | -153.44 | -17.18 |
Sale of Property, Plant & Equipment | 2.89 | 2.89 | 0.08 | 0.35 | 0.49 | 12.9 |
Cash Acquisitions | -6.65 | -6.65 | -51.66 | - | - | -295.56 |
Divestitures | 0.5 | - | - | - | - | - |
Investment in Securities | 12.52 | -63.8 | -83.99 | 103.89 | 295.24 | 116.74 |
Other Investing Activities | -149.62 | -139.99 | 9.48 | - | - | 25.85 |
Investing Cash Flow | -232.64 | -335.66 | -345.89 | -44.45 | 142.28 | -157.25 |
Long-Term Debt Issued | - | 185 | 153.73 | 48 | - | - |
Long-Term Debt Repaid | - | -108.08 | -30.39 | -55.22 | -5.93 | - |
Net Debt Issued (Repaid) | 76.72 | 76.92 | 123.34 | -7.22 | -5.93 | - |
Issuance of Common Stock | - | - | 27.92 | 314.6 | - | - |
Repurchase of Common Stock | -13.67 | -13.67 | - | - | - | - |
Common Dividends Paid | -8.08 | -14.53 | -16.25 | - | - | -3.55 |
Other Financing Activities | 8.87 | -11.61 | - | 7.88 | -205.39 | - |
Financing Cash Flow | 63.83 | 37.11 | 135.01 | 315.26 | -211.32 | -3.55 |
Net Cash Flow | -94.72 | -272.88 | -169.39 | 386.54 | 31.74 | -116.71 |
Free Cash Flow | -18.2 | -102.43 | -178.3 | -32.97 | -52.66 | 26.91 |
Free Cash Flow Growth | - | - | - | - | - | -31.24% |
Free Cash Flow Margin | -3.83% | -21.17% | -27.64% | -6.00% | -8.36% | 7.76% |
Free Cash Flow Per Share | -0.05 | -0.28 | -0.49 | -0.10 | -0.16 | 0.08 |
Cash Income Tax Paid | 34.77 | 27.77 | 44.51 | 49.61 | 68.93 | 27.71 |
Levered Free Cash Flow | 1.06 | -90.85 | -80.36 | 84.68 | -350.93 | 329.94 |
Unlevered Free Cash Flow | 6.18 | -85.66 | -77.47 | 85.71 | -350.45 | 329.94 |
Change in Working Capital | 12.64 | 12.64 | -58.59 | 8.35 | 4.48 | 43.62 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.